Aurinia Pharmaceuticals Inc (AUPH): Price and Financial Metrics

AUPH POWR Grades

• AUPH scores best on the Value dimension, with a Value rank ahead of 75.88% of US stocks.
• AUPH's strongest trending metric is Growth; it's been moving down over the last 177 days.
• AUPH's current lowest rank is in the Stability metric (where it is better than 3.89% of US stocks).

AUPH Stock Summary

• AUPH's price/sales ratio is 7; that's higher than the P/S ratio of 86.88% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.28 for AURINIA PHARMACEUTICALS INC; that's greater than it is for just 16.61% of US stocks.
• With a year-over-year growth in debt of 1,038.42%, AURINIA PHARMACEUTICALS INC's debt growth rate surpasses 98.91% of about US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to AURINIA PHARMACEUTICALS INC are NTRB, LUCD, POLA, TMDX, and SWAV.
• AUPH's SEC filings can be seen here. And to visit AURINIA PHARMACEUTICALS INC's official web site, go to www.auriniapharma.com.

AUPH Valuation Summary

• In comparison to the median Healthcare stock, AUPH's EV/EBIT ratio is 266.5% lower, now standing at -16.4.
• AUPH's price/sales ratio has moved down 116.9 over the prior 112 months.

Below are key valuation metrics over time for AUPH.

AUPH Growth Metrics

The 3 year net income to common stockholders growth rate now stands at -175.45%.
• Its 4 year price growth rate is now at 140.33%.
• Its year over year price growth rate is now at -8.67%.

AUPH's revenue has moved up $128,681,000 over the prior 33 months.

The table below shows AUPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	128.999	-115.901	-115.456
2022-06-30	87.887	-140.789	-156.722
2022-03-31	66.316	-150.897	-168.217
2021-12-31	45.605	-157.692	-180.966
2021-09-30	72.231	-126.313	-170.2
2021-06-30	57.593	-116.343	-154.009

AUPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AUPH has a Quality Grade of D, ranking ahead of 9.07% of graded US stocks.
• AUPH's asset turnover comes in at 0.178 -- ranking 206th of 682 Pharmaceutical Products stocks.
• SVRA, SESN, and VSTM are the stocks whose asset turnover ratios are most correlated with AUPH.

The table below shows AUPH's key quality metrics over time.